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Design of site-selective artiﬁcial ribonucleases (aRNases) is one of the most challenging tasks in RNA targeting. Here, we designed
and studied oligonucleotide-based aRNases containing multiple imidazole residues in the catalytic part and systematically varied
structureofcleavingconstructs.Wedemonstratedthattheribonucleaseactivityoftheconjugatesisstronglyaﬀectedbythenumber
of imidazole residues in the catalytic part, the length of a linker between the catalytic imidazole groups of the construct and the
oligonucleotide, and the type of anchor group, connecting linker structure and the oligonucleotide. Molecular modeling of the
most active aRNases showed that preferable orientation(s) of cleaving constructs strongly depend on the structure of the anchor
groupandlengthofthelinker.Theinclusionofdeoxyribothymidineanchorgroupsigniﬁcantlyreducedtheprobabilityofcleaving
groups to locate near the cleavage site, presumably due to a stacking interaction with the neighbouring nucleotide residue. Al-
together the obtained results show that dynamics factors play an important role in site-speciﬁc RNA cleavage. Remarkably high
cleavage activity was displayed by the conjugates with the most ﬂexible and extended cleaving construct, which presumably pro-
vides a better opportunity for imidazole residues to be correctly positioned in the vicinity of scissile phosphodiester bond.
1.Introduction
The idea of site-selective artiﬁcial ribonucleases which are
capable of cleaving any particular RNA sequence in vitro and
in vivo, is a very attractive approach as, apart from being use-
ful tools in molecular biology, these chemical ribonucleases
are anticipated to be helpful for target validation, and even
for the development of potential antiviral or anticancer ther-
apeutics. The idealized site-selective artiﬁcial ribonuclease
would be a compound that is easily synthesized, chemically
stable, targeted to any chosen RNA sequence, and highly
eﬃcient in cleaving of the phosphodiester bonds. The oligo-
nucleotide-based artiﬁcial ribonucleases seem to meet the
majority of these criteria due to the fact that they can be
directed to almost any desired RNA region in a site speciﬁc-
manner by controlling the sequence of the oligonucleotide
recognition part.
Virtually all types of the reactive groups, which are
known to catalyze RNA scission, have been exploited for
designandpreparationofartiﬁcialribonucleases[1–3].Con-
jugates of oligonucleotides and RNA cleaving groups can
be synthesized using two main approaches: incorporation
of a catalytic structure in the oligonucleotide in the course
of standard synthesis or by postsynthetic derivatization of
an unprotected oligonucleotide [4]. Several alternative pro-
cedures for each strategy are available. The ﬁrst approach
ofteninvolvestheautomatedoligonucleotidesynthesis,when
phosphoramidites of suitably protected nucleosides and2 Journal of Nucleic Acids
catalytic groups are used as building blocks. Monomeric
building blocks containing various metal complexes [5–8]o r
imidazole-based structures [9–16] have been previously pro-
posed for the synthesis of the oligonucleotide-based artiﬁcial
ribonucleases. The successive synthesis of oligonucleotide
and catalytic structures of conjugates on the same solid-
phase support is a promising variation of this approach [17–
19]. However, this approach is inappropriate for the majority
of the potential users of the conjugates due to the necessity
to synthesize the unique phosphoramidite derivatives of the
corresponding catalytic structures in each particular case,
which creates the problems associated with the choice of
appropriate protection groups and the deprotection proce-
dure.
Various RNA-cleaving catalysts have been tethered to the
5 -terminus of oligonucleotides. However, the available syn-
thetic methods, except for a few examples [20], allow the
incorporation of only a single functional moiety per phos-
phoramidite unit. Generally, 5 -tethering can be imple-
mented in two ways either by direct incorporation of a
suitably protected and activated constructs into the 5 -ter-
minus at the end of standard solid phase synthesis or by
postsynthetic derivatization. In the former case, synthesis of
highly modiﬁed oligonucleotides may become somewhat
problematic because increase in a number of incorporations
is expected to substantially decrease the overall yield of
the conjugated oligonucleotides. Alternatively, a precursor
molecule can ﬁrst be formed by reacting the 5 -OH group
of an assembled oligonucleotide with a heterobifunctional
reagent (ﬁrst modiﬁer) bearing both the phosphoramidite
moiety and a reactive group. The reactive group of the pre-
cursor oligonucleotide is then postsynthetically derivatized
with an appropriate functional additive (second modiﬁer)
[21, 22]. This precursor strategy has the obvious advantage
that the same parent compound can be used to synthesize a
number of diﬀerently tethered products. The ﬁrst generation
of oligonucleotide-based artiﬁcial ribonucleases, which was
prepared using the precursor technique, has recently been
reported to display high cleaving activity [23, 24]. The pre-
cursor approach seems to be advantageous for the synthesis
oflibrariesofoligonucleotideconjugatescontainingdiﬀerent
functional groups.
However, the cleavage activity of these artiﬁcial ribonu-
cleases so far has been inferior to the natural counterparts in
terms of targeting and/or cleavage eﬃciency. We anticipate
that the high level of eﬃciency of RNA cleavage by these
oligonucleotide-based artiﬁcial ribonucleases can only be
achieved if the optimal arrangement of all groups involved
in the binding and catalysis is accomplished. It might be
possible to improve on this by iterative design of the binding
and cleavage domains by taking into account the optimal
structuresofthecleavinggroupsandtheirmutualspatialori-
entationsagainsttheRNAtarget.Thestructuralorganisation
of artiﬁcial ribonucleases and the dynamic behavior of their
cleavingconstructsseemtobe the key factorscontributing to
the cleavage activity of these compounds.
Several years ago, we reported a new type of oligonu-
cleotide-based aRNases containing bis-imidazole cleaving
constructs, which were prepared by precursor technique. It
was demonstrated that these highly active bis-imidazole
cleaving constructs were extremely ﬂexible and the cleavage
of the phosphodiester bond seemed to be a random event,
which happened with the high eﬃciency every time, when
these catalytic groups approached the scissile phosphodiester
bond[23,24].Inthepresentpaper,weusethedevelopedpre-
cursor approach to synthesize the scaﬀolds of aRNases with
the systematically varied structure of the cleaving constructs
bearing multiple imidazole residues in the catalytic part.
We demonstrate here that some of these conjugates exhibit
remarkably high cleavage activity within the tRNAPhe con-
jugate hybrid and identify possible location(s) of cleaving
group(s) relative to the scissile 5 C63-A64 site. We also show,
here, that the cleaving activity of the conjugates is governed
by the intrinsic properties of the catalytic constructs, but not
thedetailedstructureoftheDNA:RNAhybrid,whichwasthe
same in all experiments.
2.MaterialsandMethods
2.1. General Chemicals. All buﬀers used in the experiments
were prepared using milliQ water, contained 0.1mM EDTA,
and were ﬁltered through ﬁlters with pore size 0.22μm( M i l -
lipore). [5 -32P]-pCp was from Biosan Co., Russia. T4 RNA
ligase was purchased from Fermentas (Lethuania). Oligo-
nucleotides TGGTGCGAATTCTG (A) and GATCGAA-
CACAGGACCT (B) were synthesized on ASM-700 DNA
Synthesizer (Biosset, Russia) by standard solid-phase phos-
phoramidite procedure. Yeast tRNAPhe was a generous gift
from Dr. G. Keith (Institut de Biologie Mol´ eculaire et Cel-
lulaire du CNRS, Strasbourg, France). Methoxyoxalamido
(MOX) modiﬁers M used for conjugate synthesis were pre-
pared as described in [21, 24].
2.2. Synthesis of Oligonucleotide Conjugates B-Im(n) Type 1,
Type 2, Type 3, and Type 4. Deoxyribooligonucleotide B
(GATCGAACACAGGACCT)wassynthesizedusingstandard
solid-phase phosphoramidite chemistry, except that the
dCBz-phosphoramidite was replaced with the dCAc-phos-
phoramidite. At the end of the automatic synthesis, the
core 17-mer was coupled with one of the modiﬁers M
(Type 1, Type 2, Type 3, or Type 4; see Figure 1)i n0 . 2M
in acetonitrile for 15min. The prepared oligonucleotide
MOX precursors were then functionalized with 2M solution
of histamine in dimethylformamide for 3hrs at 20◦Ca t
constant shaking followed by deprotection with ammonia to
produce the oligonucleotide conjugates containing multiple-
imidazole catalytic structures. The conjugates were puriﬁed
byelectrophoresisin16%polyacrylamide/8Mureagelunder
denaturing conditions. The puriﬁed conjugates were ana-
lyzed by ESI and/or MALDI MS (calculated and experimen-
tal values of molecular masses are listed in Figure 1). In
the cases when MALDI-MS analysis did not produce the
expected mass spectra due to the conjugate fragmentation
upon analysis, the conjugates were analyzed by electrophore-
sis under denaturing conditions (Figure 1(c)) and by HPLC
(primary data not shown). Conjugates were designated as
B-Im(N/m), where B-Im corresponds to the oligonucleotide
B and shows that Im are in catalytic part, N is the number ofJournal of Nucleic Acids 3
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Figure 1:Schematicrepresentationofthecatalyticstructuresofthesite-selectiveartiﬁcialribonucleasesB-Im(N/m)andanalysisoftheconjugates.
(a) Anchor groups used for attachment of dendrimeric RNA-cleaving constructs to oligonucleotide B5 -phosphate. (b) Schematic represen-
tation of conjugates bearing four and eight imidazole residues and anchor groups of Type1, Type 2, and Type 3, obtained using precursor
technology. Mass spectrometry data: 1: calculated mass 5523.30, found mass 5523.73; 2: 5566.80/5566.39; 3: 5692.89/5692.03; 4a: 6838.95/
6838,65; 5: 6423.63/6425.03. (c) Analysis of the conjugates B-Im(N/m) by 12% polyacrylamide/8M urea gel electrophoresis. 0.1 A260 unit of
each conjugate was applied on the gel; the conjugates were visualized in the gel by staining with Stains-All. Numbers on the top of the gel
correspond to numeration of the conjugates in the Table 1 and Figure 1(b) and Supplementary Material Figure 1.Journal of Nucleic Acids 5
imidazole residues (from 2 to 32), and m corresponds to the
type of anchor group (1, 2, 3, or 4; see Figure 1(a)).
2.3. Cleavage of tRNAPhe with Oligonucleotide Conjugates.
[3 -32P]-tRNAPhe was prepared and puriﬁed as described in
[24]. 3 -end labeled tRNA was dissolved in water and stored
at −20◦C. Speciﬁc radioactivity of the [32P]-tRNAPhe was
5 ×105 cpm/pmole.
Standard reaction mixture (10μL) contained imidazole
buﬀer (50mM imidazole buﬀer, pH 7.0, 200mM KCl,
0.1mM EDTA, 100μg/mL total tRNA from Escherichia coli
ascarrier),5×10
−7 M[3  -32P]-tRNAPhe,andoneofoligonu-
cleotide conjugates B-Im(N/m) at concentrations ranging
from 5 × 10
−7 to 5 × 10
−4 M (as indicated in the legends
i nt h eﬁ g u r e s ) .R e a c t i o n sw e r ec a r r i e do u ta t3 7 ◦Ca n dw e r e
quenched by precipitation of tRNA and tRNA fragments
with 150μL of 2% lithium perchlorate solution in acetone.
RNA was collected by centrifugation and dissolved in load-
ing buﬀer (6M urea, 0.025% bromophenol blue, 0.025%
xylene cyanol). tRNA cleavage products were analyzed by
electrophoresis in 12% polyacrylamide/8M urea gel. To
identify cleavage sites, an imidazole ladder [24]a n daG -
ladder produced by partial tRNA cleavage with RNase T1
[25] were run in parallel. To obtain quantitative data, the
gel was dried and analyzed using Molecular Imager FX (Bio-
Rad). The total extent of RNA cleavage was determined as
a ratio of radioactivity found in the tRNA fragments to total
radioactivity applied on the gel lane.
To measure the kinetics of the tRNA cleavage with the
oligonucleotideconjugatesB-Im(N/m),thereactionmixture
of 100μL was prepared containing imidazole buﬀer, 5 ×
10
−7 M3  -[32P]-tRNAPhe and one of the oligonucleotide
conjugates B-Im(N/m)at diﬀerent concentrations (from 5×
10
−7 to 5 × 10
−4 M). Reaction was performed at 37◦C. At
indicated time intervals, an aliquot (10μL) of the reaction
mixture was withdrawn and frozen for lately assay. Reaction
aliquots were defrosted and immediately precipitated with
150μL 2% lithium perchlorate in acetone. After that, the
reaction mixtures were assayed as described above.
In some experiments, imidazole buﬀer was replaced by
HEPES-buﬀer (50mM HEPES-KOH, pH 7.0; 0.2M KCl,
0.1mM EDTA, 100μg/mL RNA-carrier), or Cacodylate
buﬀer (50mM Cacodylic acid-KOH, pH 7.0; 0.2M KCl,
0.1mM EDTA, 100μg/mL RNA-carrier) or Tris-HCl-buﬀer
(50mM Tris-HCl, pH 7.0; 0.2M KCl, 0.1mM EDTA,
100μg/mL RNA-carrier). The experiments where imidazole
buﬀer was replaced by other buﬀers are indicated in text and
ﬁgure legends.
2.4. Inhibition of Site-Selective tRNAPhe Cleavage by Oligonu-
cleotide Competitor. In the competition experiments, to
a reaction mixtures (10μL) containing imidazole buﬀer,
5 ×10
−7 M3  -[32P]-tRNAPhe oligonucleotide A (comple-
mentary to sequence 62-76 of the tRNAPhe) or oligonu-
cleotide B was added up to concentration 5 × 10
−5 M. The
mixtures were incubated for 10min at 37◦C, then one of
oligonucleotide conjugates B-Im(N/m) at concentration 5 ×
10
−6 M was added and the mixtures were incubated at
37◦Cf o rd i ﬀerent times (from 30min to 2h). Reaction was
q u e n c h e da n da n a l y z e da sd e s c r i b e da b o v e .
2.5. Gel-Mobility Shift Assay of Hybridization of Oligonu-
cleotide B and Conjugates B-Im(4/2) to tRNAPhe. A gel-mo-
bility shift assay of tRNAPhe binding with oligonucleotide B
and conjugates B-Im(4/2) was performed as follows. [3 -32P]
tRNA (5 × 10
−7 M) was incubated at 37◦C during 30min
in reaction mixture (10μL) containing hybridization buﬀer
(50mM Tris-HCI, pH 7.0, 200mM KCI, 0.1mM EDTA)
and oligonucleotide B or conjugate B-Im(4/2) ranging in
concentration from 1×10
−7 to 5×10
−6 M. After incubation,
8μL of loading buﬀer (50% glycerol, 0.025% bromophenol
blue, 0.025xylene cyanol) was added to each probe and
probes were immediately applied onto running native 10%
PAGE with 100mM Tris-borate, pH 8.3 as running buﬀer
preequilibrated at 4◦C for 3h. Electrophoresis was per-
formed at 4◦C for 5h at 450V. To obtain quantitative data,
the gel was dried and analyzed using Molecular Imager FX
(Bio-Rad).
2.6. Molecular Modelling. Molecular modelling was per-
formed using SYBYL 6.6 (TRIPOS Inc.) on a Silicon Graph-
ics O2 workstation as described in [24]. All calculations
(MM/MD) were carried out in vacuo using Kollman-All
force ﬁeld parameters and a distance-dependent dielectric
constant equal to 4. The building of the model molecules
(see Figure 1) was carried out in three stages. First, an A-like
DNA:RNA hybrid was built using BIOPOLYMER/SYBYL
6.6. Second, the catalytic fragments Im(4/1), Im(4/2a),a n d
Im(4/2b) were built using SKETCH/SYBYL 6.6. Charge dis-
tributions for these constructs were calculated using a semi-
empirical MO program, MOPAC, after geometric optimiza-
tion. In the last step, each the corresponding cleaving frag-
ment was attached to the DNA:RNA hybrid via the terminal
5 -phosphate group of the G1 nucleotide residue.
F o re a c hm o l e c u l e ,s e v e r a ld i ﬀerent starting structures
were created, diﬀering in the conformation and location of
the cleaving group, ranging from “in” to “out” extreme posi-
tions relative to the DNA:RNA hybrid. The starting struc-
tures of each molecule were subjected to minimization to
a gradient convergence of 0.05Kcal/mol, considering the
DNA:RNA hybrid as a solid body. Each starting structure
wasindividuallysubjectedtoa12psMDrunusingsimulated
annealing as follows. The system was heated at 600K during
2ps followed by a gradual cooling down to 100K over 10ps.
A ﬁnal minimization to convergence criteria was performed
resulting in the respective ﬁnal conformations for each type
of molecule. S and F symbols before the conjugate name in-
dicate the starting and ﬁnal conformation, respectively.
“Active conformations” were obtained for each model
molecule (O1-Im4/1, O2-Im4/1 O1-Im4/2a, O2-Im4/2a,
O1-Im4/2b, and O2-Im4/2b, where Type1 shows the anchor
group 1) using a similar simulating annealing protocol.
In these molecules, the cleaving groups were deliberately
located in the most favorable position for successful cleavage
attheC63-A64 site.Namely,thedistancebetweenN1ofoneof
the imidazole residues and 2  OH group of C63 was ∼3 ˚ Aa n d
the distance between N1 of the other imidazole residue and6 Journal of Nucleic Acids
Table 1: Oligonucleotide-based artiﬁcial ribonucleases bearing multiple imidazole groups in the catalytic part: structure of conjugates and
eﬃciencies of site-speciﬁc cleavage of yeast tRNAPhe.
Conjugate1 Number of Im groups Anchor group2 Linker length3 Reaction rate, %/1h4 Reaction 1/2τ5
1 B-Im(2/1) 2 1/2 21 24.8 2h 15/∗
2 B-Im(2/2) 2 2 20 25.3 2h 5/∗
3 B-Im(4/1) 4 1 41 49.8 1h 5/
4a B-Im(4/2a) 4 2 29 16.6 2h 50/
4b B-Im(4/2b) 4 2 26 5.5 >12h
5 B-Im(4/3) 4 3 18/22 ∼1— 6
6 B-Im(8/1) 8 1 41 45.1 1h 15/
7 B-Im(8/2) 8 2 41 29.7 2h
8 B-Im(8/2+1) 8 1 49 31.3 1h 45/
9 B-Im(16/1) 16 1 70 38.5 2h 10/
10 B-Im(8/4+1) 8 4 23/31/41 29.1 2h
11 B-Im(12/4+2) 12 4 23/31/51 33.8 1h 40/
12 B-Im(24/4+2) 24 2 41/79 49.9 1h
13 B-Im(32/4+2) 32 1 41/98 20 2h 30/
1The structures of the conjugates are shown in Figure 1 and in Supplementary material (SM-Figure 1).
2ThetypeofanchorgroupsoftheconjugatesasshowninFigure 1(a).Type1:cyclohexanolmoiety;2:5/-aminothymidineresidue;3:nonnucleotideinsertion;
4: 2/-modiﬁed uridine residue.
3The number of simple C–C, C–N, or P–O bonds between the 5/-terminal phosphate group of oligonucleotide B and imidazole groups of RNA-cleaving
construct.
4Eﬃciency of the RNA cleavage was measured as percentage of tRNAPhe cleavage at C63-A64 phosphodiester bond achieved after incubation during 1h in the
presence of 10μMo ft h ec o n j u g a t e .
5Time to reach 50% of tRNA cleavage under the standard conditions (see above) at conjugates concentration 10−5 M.
650% of tRNAPhe cleavage was not achieved under experimental conditions.
∗These conjugates are described in the preceding paper [1].
the oxygen of the phosphate group, connecting C63 and A64,
wasaround3 ˚ A[26,27].Aﬁnalminimizationwasperformed
without constraints, using the above protocol.
3. Results andDiscussion
3.1. Design of Oligonucleotide-Based Artiﬁcial Ribonucleases.
The RNA cleaving oligonucleotide conjugates have been pre-
pared in two-step procedure described in [21, 22]. In the ﬁrst
step, the precursor 17-mer GATCGAACACAGGACCT (B)
was built up with multiple methoxyoxalamido (MOX) mod-
iﬁers of diﬀerent type (see Supplementary Material available
online at doi:10.4061/2011/748632 for the structures of all
conjugates synthesized in this study). In the second step, the
prepared oligonucleotide-MOX precursors were function-
alized with histamine to yield after deprotection step the
oligonucleotide conjugates B-Im(N/m),b e a ri n gf r o m4t o3 2
histamine residues at the 5 -end.
Figure 1 provides structures of oligonucleotide conju-
gates B-Im(4/n) and B-Im(8/1) studied in this work. The
conjugates hereafter were referred to as B-Im(N/m),w h e r e
B-Imdesignatestheoligonucleotide-imidazoleconjugates,N
shows the number of imidazole residues, and m indicates
the type of anchor group. In the cases, when two or three
conjugates contain equal number of imidazole residues and
the same anchor group, the conjugate number is shown
in the brackets. The distance between oligonucleotide and
imidazole residues of the cleaving part was varied by
altering the structures of the anchor and the linker groups.
Cyclohexyl residue was exploited as anchor group in the
conjugate Type 1. Thymidine nucleoside was used to anchor
the catalytic part in the conjugate Type 2. The thymidine
nucleoside,presentinginthestructureofconjugate,wassup-
posed to be involved in base pairing with RNA or might be
stacked on heteroduplex contributing to the duplex stability.
In the conjugate Type 3, an anchor group was chemical con-
struct mimicking phosphodiester bond and used as a rule as
nonnucleotide insertion in oligonucleotide. Type 4 anchor
group was used in the conjugates 10–13 to increase the num-
ber of branches, bearing imidazole residues. For this purpose
and to increase the linker length and ﬂexibility, the anchor
groupsofTypes1and2wereincorporatedalsointothelinker
structures (see Figure 1-SM, conjugates 6–9 and 11–13).
Moreover, the length and structure of linkers, connecting
imidazole residues and anchor, were distinguished suﬃ-
ciently among the compounds (Table 1 and Figure 1-SM).
Conjugates containing equal number of imidazole residues,
for example, B-Im(4/m) or B-Im(8/m),d i ﬀer not only in
anchor groups, but also in a linker length. The linker of
conjugate B-Im(4/3) was the shortest one. In this conjugate,
four imidazole residues were placed nonsymmetrically in
respect to the phosphate groups forming the anchor, which
connected the oligonucleotide B and the cleaving construct.
The identity of the conjugates was conﬁrmed by mass-
spectrometry; (see Figure 1). In addition, the purity of the
conjugates was conﬁrmed by electrophoresis in 12% PAAM/
8Mureagel(Figure 1(c)). It is seen that the purity of the
conjugates is close to 95%. Only in the case of conjugates 2,Journal of Nucleic Acids 7
5, 10,a n d16, some other bands with the relative intensities
of 5–7% are seen.
3.2. Cleavage of Yeast tRNAPhe by the Conjugates Bearing Mul-
tiple Imidazole Residues. Yeast tRNAPhe was chosen deliber-
ately as a target to assess cleavage activity of the conjugates.
The rationale behind this was that other oligonucleotide-
based aRNases including three prepared using precursor
approach had been tested using this target [1, 12, 14–16, 28].
Figure 2(a) represents cloverleaf structure of yeast tRNAPhe
showing the target site for the conjugates B-R(N/m).T h e
recognition element of the studied aRNases was represented
by the 17-mer oligonucleotide B, which was complementary
to the sequence 44-60 and was designed to deliver the
imidazole residues to the sequence 61CACAG65 in the T-arm
ofthetRNAPhe,whichisknowntobehighlysensitivetowards
cleavage [29–32]. It was previously shown that oligonu-
cleotide B could eﬃciently bind to this sequence in the
tRNAPhe, which resulted in unfolding of entire TΨC hairpin,
whereastheaminoacceptorandanticodonstemsofthetRNA
were only slightly aﬀected by the oligonucleotide binding
[33–35].
The conjugates B-Im(N/m) were designed to catalyze
RNA cleavage via transesteriﬁcation reaction. To compare
theribonucleaseactivitiesoftheconjugates,weusedthecon-
ditions of single reaction turnover ([B-Im(N/m)]>[RNA]).
The oligonucleotide part of the conjugate provides eﬃcient
hybridization with target sequence in tRNAPhe and forma-
tionofthestableheteroduplex(Kd =7μM ±1μM;V.Petyuk,
unpublished data). We believe that under the experimental
conditions the rate and eﬃciency of site-selective cleavage
of the target is aﬀected only by the catalytic part of the
conjugate.
Site-selective cleavage of [3 -32P]tRNAPhe by the conju-
gates was carried out at 37◦Ci n5 0 m Mi m i d a z o l eb u ﬀer.
The reaction was initiated by addition of the conjugate
B-Im(N/m)tothereactionmixtures.Localizationofcleavage
sites was performed by comparison of products obtained
upon cleavage of tRNA by the conjugates with the products
of random RNA cleavage with RNase T1 and 2M imidazole
buﬀer, pH 7.0 [25, 36]. Figure 2(b) shows typical results
of the analysis of tRNAPhe cleavage by the conjugates B-
Im(N/m)at37◦Cunder standardconditions. No measurable
spontaneous degradation of tRNA under the experimental
conditions in the absence of reagents and in the presence of
unmodiﬁed parent oligonucleotide B occurred (Figure 2(a),
lanes C1 and C2). The conjugates cleave tRNAPhe with high
rate mostly at the phosphodiester bonds C63-A64 and A64-
G65. The extents of tRNAPhe cleavage at these bonds are
about 70% and 20%, respectively. Moreover, some minor
cleavage at the phosphodiester bonds C61-A62 and A62-C63
within the target sequence is observed (Figure 2(a), lanes 1–
10).TheratiobetweentheproductsoftRNAcleavageatthese
phosphodiester bonds located in close proximity to each
other in the target sequence seems to correspond to steric
accessibility of these bonds to cleavage by the conjugates
B-Im(N/m). In the case of conjugate B-Im(4/2a) (similar
cleavages were observed for the conjugates with 16, 24,
and 32 imidazole residues), slight cleavages are observed at
U8-A9 and C75-A76 phosphodiester bonds (less then 3% of
the total extent of tRNA cleavage), known as well as C61-
A62 and C63-A64 bonds in the yeast tRNAPhe to be very
sensitive toward cleavage by various agents [29–32]. The
bondU8-A9islocatedintheproximitytosequenceC61-G65
if tertiary structure of tRNAPhe is taken into account. Thus,
one may assume that the observed cleavage of this bond
occurs in complementary complex formed by conjugate
B-Im(N/m)withtRNAandistheresultofﬂexibilityofRNA-
cleavinggroupoftheconjugates.Besides,wecanassumethat
initial cleavage of phosphodiester bond C63-A64 produces
a nick in tRNA molecule that may increase the ﬂexibility of
the complex tRNA-conjugate B-Im(N/m) and thus makes
phosphodiester bonds C64-G65 and U8-A9 available for
catalyst’s function groups. The slight cleavage observed at
C75-A76 site apparently is the result of spontaneous tRNA
hydrolysis in the duplex with the conjugate.
Competition experiments were used to prove that tRNA
cleavage occurs in tRNA-conjugate complex. tRNAPhe cleav-
age by conjugate B-Im(4/1) was performed in the presence
of oligonucleotide inhibitors of two types: parent oligonu-
cleotide B and oligonucleotide A complementary to the se-
quence 61-75 (Figure 2(b), lanes 17–19). As expected, the
cleavage of tRNAPhe by conjugate B-Im(4/1) is considerably
decreased in the presence of oligonucleotides B (primary
data not shown) and is completely abolished in the presence
of oligonucleotide A, which protects target sequence by
duplex formation. It is worth noting that in the presence
of oligonucleotides B, the cleavage of tRNAPhe is suppressed
in all sites due to competitive binding, whereas oligonu-
cleotides A inhibit tRNAPhe cleavage only at the target se-
quence failing to change reaction rate at other sites. These
resultsindicatethestructuralspeciﬁcityofcleavageandstress
the fact that the cleavage occurs only at a single-stranded
target sequence.
Figure 2(c) shows concentration dependencies of the
cleavage reaction for conjugates B-Im(4/1) (3) and Im(24/
4+2)(11)(curves1and2,resp.)andbindingoftheconjugate
B-Im(4/2a) and parent oligonucleotide B with tRNA (curves
3 and 4, resp.). It is seen that the cleavage data are in agree-
ment with the complex formation. Furthermore, the binding
aﬃnity of the parent oligonucleotide and the conjugate
studied under identical conditions are found to be similar
(Figure 2(c)).Therefore,theconjugationofbulkyimidazole-
containing reactive groups to the oligonucleotide does not
aﬀect the hybridization process.
To estimate the inﬂuence of buﬀer on eﬃciency of
site-selective RNA cleavage, we compared tRNAPhe cleavage
by the conjugate B-Im(4/2) in diﬀerent buﬀer solutions
(Figure 2(d)), taken 50mM imidazole buﬀer, pH 7.0 as a
standard conditions. The rate of site-selective cleavage is
aﬀected by replacement of 50mM imidazole buﬀer, pH 7.0,
by 50mM Tris-HCl buﬀer or 50mM cacodylate buﬀer at
pH 7.0 by the factor of 1.5 indicating that imidazole itself
may contribute to cleavage reaction. At longer incubation
time, this diﬀerence became insigniﬁcant and does not
exceed estimated experimental error. Surprisingly, 50mM
HEPES buﬀer entirely abolishes cleavage inactivating the
conjugates. The reason of this is not entirely understood.8 Journal of Nucleic Acids
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Figure 2: Site-selective cleavage of yeast tRNAPhe by the oligonucleotide conjugates bearing multiple imidazole residues in the catalytic part.Journal of Nucleic Acids 9
One explanation could be that sulfonic acid of HEPES [4-(2-
hydroxyethyl)-piperazine-1-ethanesulfonic acid] may inter-
act with protonated imidazole residues of the conjugates and
inactivate it. Previously, we also observed twofold decrease
of the rate of RNA cleavage by oligonucleotide conjugate
bearing two imidazole residues in 50mM HEPES-KOH
buﬀer,whereastheotherbuﬀersonlyslightlyaﬀectedtherate
o fR N Ac l e a v a g e[ 37].
In Figure 2, (a) represents cloverleaf structure of yeast
tRNAPhe and target sequences for oligonucleotide B-based
artiﬁcial ribonucleases B-Im(N/m). Bold letters show target
sequence for oligonucleotide-competitor A. Arrows indicate
the sites of site-selective tRNA cleavage by the conjugates;
(b) represents cleavage of tRNAPhe with oligonucleotide con-
jugates B-Im(4/m). Autoradiograph of 12% polyacrylamide
/8M urea gel. Cleavage reactions were performed at 37◦Ci n
50mM imidazole buﬀer, pH 7.0, containing 200mM KCl,
0.2mM EDTA, 100μg/mL RNA carrier, 5 × 10
−7 M[ 3  -
32P]tRNAPhe and1×10
−5 MoneoftheconjugatesB-Im(4/1),
B-Im(4/2a),a n dB-Im(4/2b). Lanes L and T1 are Imidazole
and RNase T1 ladders, respectively. Lanes C1 and C2 are
tRNA incubated in the reaction buﬀer for 8h in the absence
and in the presence of oligonucleotide B (5 × 10
−5 M),
respectively. tRNA cleavage by conjugate B-Im(4/1) (3) for
0.5, 1, 3, 5, and 8h (lanes 1–5, resp.), by conjugate B-
Im(4/2a) (4a) f o r0 . 5 ,1 ,3 ,5 ,a n d8h( l a n e s6 – 1 0 ) ,b yt h e
conjugate B-Im(4/2b) (4b) f o r0 . 5 ,1 ,3 ,7 ,1 0 ,a n d1 8 h
(lanes 11–16); by the conjugateB-Im(4/1)(3)in the presence
of oligonucleotide A (1 × 10
−4) for 0.5, 1, and 5h (lanes
17–19). Concentration of the conjugates in the reaction
mixtures was 1 × 10
−5 M. Reactions were quenched and
analyzed as described in the experimental part;(c) represents
concentration dependencies of the tRNAPhe cleavage by the
conjugates B-Im(4/1)(3) and B-Im(24/2) (12) (curves 1 and
2, resp.) and complex formation with the conjugate B-Im(4/
2a) (4a) (curve 3) and parent oligonucleotide B (curve 4).
The reaction mixtures were incubated for 2h under the
conditions described above; (d) represents the inﬂuence of
the buﬀer nature on the rate of tRNAPhe cleavage by the
conjugate B-Im(4/2a) (4a).[ 3  -32P]tRNAPhe (0.5μM) was
incubated with 2μMo f(4a), in 50mM imidazole buﬀer,
p H7 . 0( I m )o r5 0m Mc a c o d y l a t eb u ﬀer, pH 7.0 (Cac) or
50mM Tris-HCl buﬀer, pH 7.0 (Tris) or 50mM HEPES
buﬀer, pH 7.0 (Hepes) containing 0.2M KCl, 0.2mM EDTA,
and 0.1mg/mL RNA carrier.
3.3. Kinetics of tRNAPhe Cleavage by the Conjugates.
Figure 3(a) displays the kinetics of tRNAPhe cleavage with
conjugates under the study taken at conjugate concentration
10μM. It is seen that the conjugates cleave RNA with
diﬀerent eﬃcacy. One of the most eﬀective conjugate is
B-Im(4/1), as complete site-selective cleavage of the target
by this conjugate is achieved within 2-3 hours. Similar
kinetics are displayed by the conjugate B-Im(8/1) (6)a n d
the B-Im(24/4+2) (12). The conjugates B-Im(4/2a) (4a)
and B-Im(8/2) (7) catalyze RNA cleavage less eﬃciently as
compared with B-Im(4/1) or B-Im(8/1).C l e a v a g ee ﬃciency
of the conjugate B-Im(4/3) (5) was essentially poor.
Figure 3(b) shows kinetic curves of tRNAPhe cleavage by
conjugate B-Im(4/1) obtained at diﬀerent concentrations of
the conjugate. The character of kinetic curves evidences the
bimolecular reaction: the rate of RNA cleavage is increased
with the increasing of the conjugate concentrations. At con-
centration of conjugate B-Im(4/1) of 10μM, which provides
itsalmostquantitativebindingtotRNA,thehalf-lifeoftRNA
i sa b o u t1h( Figure 3(b), curve “10μM” ). When concentra-
tion of conjugate B-Im(4/1) is increased up to 50μM, the
half-life of tRNA is counted by minutes (Figure 3(b),c u r v e
“50μM”). It should be noted that the site-selective cleavage
of tRNA proceeds much slower than the binding of the
parent oligonucleotide B to tRNA under similar conditions
[33–35]. At concentration of the conjugate equal to or twice
as higher as concentration of the tRNA, the curves reveal
lag period (Figure 3(b), curves “0.5” and “1μM,” resp.) in-
dicating that the process of site-selective RNA cleavage
includesseveralconsecutivestepsoccurringwithcomparable
rates. Another explanation of this could be that the reaction
has more complex character and goes through some stages
other than binding of the conjugate and cleavage, which
results in sigmoid-like kinetic curve.
For conjugate B-Im(4/1), we calculated the association
rate and cleavage rate constants from the data shown in
Figure 3(b), assuming that cleavage of the tRNA occurs
within the complex with the conjugate. In this case, hy-
bridization step is the second-order reaction and cleavage
stage is intramolecular ﬁrst-order reaction. It turns out
that cleavage pe se occurs 50times faster than the bind-
ing of the conjugate with the complementary sequence
within RNA target (association rate constant and cleavage
rate constant are (0.074 ± 0.002) M−1 s−1 and (3.4 ±
0.55)×10
−3 s−1, resp.). In other word, binding of the conju-
gatewithtRNAistherate-limitingstageofsite-selectiveRNA
cleavage.
3.4. Correlations between Structure and Activity of the Conju-
gates Bearing Multiple Imidazole Groups. The conjugates dis-
play diﬀerent cleavage activities (Table 1) ranging from very
highcleavagerate(τ1/2 ∼1hinthecaseof B-Im(4/1))t ov ery
low (τ1/2 value was not achieved under the experimental
conditions in the case of B-Im(4/3)). Remarkable cleaving
activity of the conjugates 3, 6,a n d12 as well as moderate
cleavage activity of the conjugates 4a, 8, 10, 11,a n d13
and poor eﬃciency of the conjugate 5 are likely resulted
from the diﬀerences in the structure of the catalytic part
of the conjugates rather than due to diﬀerent hybridization
properties and the cleavage reaction pe se.T h ec o n j u g a t e s
under the study contain identical oligonucleotide recogni-
tion element and display similar cleavage speciﬁcity with
only minor diﬀerences in the cleavage pattern. Therefore,
neither hybridization nor sensitivity of the phosphodiester
bonds toward the cleavage could explain the diﬀerences in
the catalytic properties of the conjugates. Even the catalytic
parts of the conjugates in several cases contain the equal
number of imidazole residues.
Table 1 summarizes data on the cleavage activity and
structure of the conjugates under the study (linker length in10 Journal of Nucleic Acids
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Figure 3:Kinetics of tRNA Phe cleavagebytheconjugates:(a)tRN Aclea vageb yB-Im(4/1)(3)(rhombs),B-Im(4/2a)(4a)(squares),B-Im(4/3)
(5), (asterisks), B-Im(8/4+1) (10) (triangles), and B-Im(24/4+2) (12) (crosses) under standard conditions at conjugates concentration
10μM. (b) tRNA cleavage by B-Im(4/1) (3) at concentrations ranging from 0.5 to 50μM.
total number of simple C–C, C–N, C–O, and P–O bonds
between 5/-end of oligonucleotide B and imidazole residues,
type of anchor group, and reaction halftimes). It is seen that
hydrolyticactivityofcompoundsisinagoodagreementwith
the length of their linkers (Table 1). Amongst the conjugates
bearing four imidazole residues, the highest cleavage activity
is observed for the conjugate B-Im(4/1), which has the
linkers of 41 simple bonds. The conjugates B-Im(4/2a) with
thelinkersof29chemicalbondsexhibit3-foldlowercleavage
activity,whereasB-Im(4/3) (18/24 bonds) cleavestRNAwith
lowesteﬃciency.Thus,stepwiseshorteningofalinkerpartof
conjugate B-Im(4/m) from 41 to 18/24 simple bonds results
in decreasing of cleavage eﬃciency from 50% per hour to
1% per hour. As it is seen from Table 1, only the conjugates
containing the linkers of 40 simple bonds are capable of
eﬃciently catalyzing cleavage of tRNAPhe in a site-selective
manner. Thus, we can conclude that a long ﬂexible linker of
40 or more simple C–C, C–N, or P–O bonds is required for
eﬃcient site-selective cleavage of RNA target.
Figure 4 display Structure-Activity correlations found for
the conjugates B-Im(N/m). It is seen that cleavage activity
of the conjugates B-Im(N/1) depends on the number of
imidazole groups in the catalytic part (Figure 4(a)). The
conjugates bearing 4 and 8 imidazole residues exhibit the
highest cleavage activity, while increasing of the number of
imidazole groups inhibits cleavage. It is worth pointing out
that sigmoidicity of kinetic curves taken under identical
conditions is increased with increasing of the number of
imidazoles in the conjugate (primary data not shown). It is
likely that cleavage activity of these conjugates is aﬀectedbya
steric interference between imidazoles, thus leading to a loss
of cleavage rate. Therefore, four (and/or eight) imidazole
residues in the catalytic part of the conjugate seem to be
suﬃcient for eﬃcient RNA cleavage.
From the data shown in Figure 4(b),i ti ss e e nt h a tr i b o -
nuclease activity of the conjugates depends on type of the
anchor group used for attachment of parent oligonucleotide
to RNA-cleaving construct. The conjugates with Type 1
anchor group (B-Im(N/1)), cyclohexyl moiety (Figure 1(a)),
display higher cleavage activity than conjugates with the
anchor group in a form of thymidine residue (Type 2,
Figure 1) and especially than conjugates with a nonnucleo-
side anchor group (Type 3, Figure 1)( Table 1). The diﬀer-
ence between cleavage activity of the conjugates with Type
2 and Type 4 anchor groups does not exceed experimental
error, but is reliably lower than that for conjugates with Type
1 anchor group. Thus, the structure and ﬂexibility of the
linker part, the number of imidazole residues in the catalytic
part, and the type of anchor group aﬀect cleavage activity of
the conjugates and play a role in the optimal positioning of
the catalyst in respect to scissile phosphodiester bond.
3.5. Molecular Modeling Study. The main goal of the molec-
ular modelling was to clarify the following issues.
(1) Is there any preferable orientation(s) of the cleaving
group(s) in the vicinity of the cleavage site, which
could explain the hydrolytic activity (or its absence)
of each conjugate?
(2) Is there any evidence of interaction(s) between the
cleaving constructions and the DNA:RNA hybrid,
which could stabilize preferable orientation(s) of
these groups near the cleavage site?
(3) What is the correlation between the structure of the
cleaving constructs and the linker groups and their
hydrolytic activity?
It is evident from the biochemical assays that hydrolytic
activity within the heteroduplex tRNA Phe-conjugate is gov-
erned by the intrinsic properties of the cleaving constructs,
but not the detailed structure of the DNA-RNA hybrid,
which was the same in all experiments. Therefore, the main
priority was to identify possible location(s) of the cleavingJournal of Nucleic Acids 11
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group(s) relatively to the cleavage site rather than to deter-
mine the detailed conformation of the hybrid (which would
be impossible in the absence of relevant NMR/X-ray data).
Ithasbeenshownearlierthathybridizationoflongoligo-
nucleotides to TΨC-loop [33, 38] or to the 3 -acceptor stem
[33–35] of tRNA induced a local unfolding of the tRNA
secondary structure. Therefore, we assumed that the hybrid
part of the molecules under the study can be represented
to a ﬁrst approximation by a double-stranded DNA:RNA
duplex,whichwouldformprimarilyanA-likeconformation,
according to physicochemical investigations [39–41]. In our
molecular modeling studies, we used a shortened model for
the heteroduplex, comprising the target RNA sequence
(corresponding to the 5 A44-U69 fragment of tRNAPhe)a n d
the oligodeoxyribonucleotide conjugate complementary to
this RNA region (Figure 2(a)).
Based on this hybrid duplex, three model molecules
were created (M-Im(4/1), M-Im(4/2a), and M-Im(4/2b)) by
attachment of the respective cleaving constructs to the 5 
terminal phosphate group of the G1 nucleotide residue (see
Figures 1 and 2). At this stage, in the absence of the detailed
structural data for the hybridized heteroduplex, it was rea-
sonable to treat the hybrid as a “solid” structure [24] whilst
allowing cleaving constructs to possess a full conformational
ﬂexibility during the calculations.
For each molecule M-Im(4/1), M-Im(4/2a), and M-
Im(4/2b), several starting structures were created diﬀering in
the spatial orientation of the cleaving construct(s), ranging
from “in” to “out” extremes (see “Section 2”). This increased
the conformational space searched for each model molecule.
All starting structures were subjected to independent simu-
lating annealing (see “Section 2”) giving rise to the respec-
tive ﬁnal structures (M-Im(4/1): F1-Im(4/1)–F9-Im(4/1);
M-Im(4/2a): F1-Im(4/2a)–F9-Im(4/2a); M-Im(4/2b): F1-
Im(4/2b)–F9-Im(4/2b).
Both structural parameters and energy values of each
ﬁnal structure were analyzed and compared with those of
“active” conformations (O1-Im(4/1), O2-Im(4/1), O1-Im(4/
2a), O2-Im(4/2a), O1-Im(4/2b), and O2-Im(4/2b)), which
had deliberately preorganized cleaving centers according to
[20, 26, 27, 42, 43]( s e e“ Section 2”) (Table 2).
Molecules containing four imidazole residues M-Im(4/
1), M-Im(4/2a), and M-Im(4/2b), having two bis-imidazole
cleaving constructs, diﬀer in the geometrical properties of
their linker groups (see Figure 1). The linker group of
M-Im(4/1) possess a cyclohexyl fragment connecting the
cleaving moieties with the oligonucleotide. In M-Im(4/2a),
the cyclohexyl fragment is replaced by a deoxyribothymidine
fragment. M-Im(4/2b) is a shorter analogue of M-Im(4/2a).
For each molecule, nine ﬁnal structures plus two “opti-
mal” conformations were obtained as a result of the sim-
ulated annealing calculations. The data on the distances
between N1 atoms of imidazole rings and target site as well
as energy values are presented in Table 2.
ForM-Im(4/1)(Table 2),themostenergeticallyfavorable
conformations (O1-Im(4/1), O2-Im(4/1), and F4-Im(4/1))
are characterized by the location of at least two imida-
zole groups close to the target site (3–7 ˚ A). In the most
cases, M-Im(4/2a) conformers have at least one imidazole
group located near the cleavage site, which suggests a high
probability for cleaving groups to form a preorganized12 Journal of Nucleic Acids
Table 2: Distances between active centers of the conjugates B-Im(4/m) and RNA target atoms.
Molecule Final structure Energy (kcal/mol)
ΔE (kcal/mol) Dist. Pair 1(E) Dist. Pair 2(E)
for O1 for O2 Im1-OH(a) Im2-OP(b) Im1-OH Im2-OP
M-Im(4/1)
F1- Im(4/1) 47.3 18.2 13 6.2 11.4 26.6 21
F2- Im(4/1) 66.7 37.6 32.4 6.2 14.3 21.1 22.9
F3- Im(4/1) 48.3 19.2 14.0 6.6 16.3 23.0 33.9
F4- Im(4/1) 28.6 −0.6 −5.8 7.1 7.0 2.9 7.5
F5- Im(4/1) 60.2 31.1 25.9 7.5 17.2 11.8 11.5
F6- Im(4/1) 42.6 13.5 8.3 12.8 9 23.1 13.4
F7- Im(4/1) 54.9 25.8 20.5 11.9 12.7 15.7 25.9
F8- Im(4/1) 47.3 18.2 13.0 7.3 15.0 24.8 21.0
F9- Im(4/1) 49.8 20.7 15.5 10.7 17.0 16.5 23.7
O1- Im(4/1) 29.1 —— 3.0 3.0 12.9 23.1
O2- Im(4/1) 34.3 — — 23.5 25.7 3.2 3.3
M-Im(4/2a)
F1- Im(4/2a) −6.7 −4.3 −5.8 12.4 25.1 26.4 19.8
F2- Im(4/2a) 24.0 26.3 24.8 23.1 15.6 23.2 34.8
F3- Im(4/2a) 0.5 2.9 1.4 21.1 11.6 21.3 19.8
F4- Im(4/2a) 9.7 12.0 10.5 6.4 15.8 23.3 27.8
F5- Im(4/2a) 1.7 4.0 2.5 5.6 10.1 21.6 26.7
F6- Im(4/2a) 23.4 25.8 24.3 26.1 30.6 16.2 8.6
F7- Im(4/2a) 23.4 25.8 24.3 26.1 30.6 16.2 8.6
F8- Im(4/2a) 0.5 2.9 1.4 21.2 11.6 24.4 17.4
F9- Im(4/2a) 13.3 15.6 14.1 14.4 18.4 28.2 27.8
O1- Im(4/2a) −2.4 —— 3.17 3.0 20.1 33.7
O2- Im(4/2a) −0.9 — — 17.7 17.6 3.0 3.2
M-Im(4/2b)
F1- Im(4/2b) −4.7 6.9 −16.2 23.7 15.9 21.4 19.9
F2- Im(4/2b) −17.9 −6.3 −29.3 30.9 32.7 21.9 30.7
F3- Im(4/2b) −17.8 −6.2 −29.2 27.6 36.0 25.9 21.9
F4- Im(4/2b) 0.1 11.7 −11.3 5.3 23.3 14.5 14.3
F5- Im(4/2b) −9.1 2.5 −20.5 21.1 26.2 23.5 25.8
F6- Im(4/2b) 0.1 11.7 −11.3 18.5 9.2 11.3 19.7
F7- Im(4/2b) 0.1 11.7 −11.3 18.5 9.2 11.3 19.7
F8- Im(4/2b) −6.7 4.9 −18.1 9.0 10.6 20.7 23.3
F9- Im(4/2b) −2.5 9.1 −13.9 14.9 30.4 27.9 31.8
O1-Type3 −11.6 —— 3.1 3.0 13.4 14.9
O2-Type3 11.4 — — 25.2 27.2 3.0 3.0
(a)Im1-OH represents the distance between N1 of one of the imidazole residues and the 2 OH group of C63.
(b)Im2-OP represents the distance between N1 of the other imidazole residue and the oxygen of the phosphate group connecting C63and A64.
“active” conformation. These data are in agreement with
the biochemical assays on high hydrolytic activity seen for
B-Im(4/2a) conjugate, showing that this compound reaches
the maximum activity (49.8%) found for artiﬁcial ribonu-
cleases. Figure 5 represents the fragments of the F4-Im(4/1)
structure, as the most energetically favorable conformation
of M-Im(4/1), and shows the probable orientation of the
cleaving groups.
In the case of M-Im(4/2a), most of the ﬁnal struc-
tures obtained in the simulated annealing experiments are
characterized by a distant location of cleaving groups from
the target site (Table 2). For example, the lowest-energy
structures F1-Im(4/2a), F3-Im(4/2a), and F8-Im(4/2a) have
veryunfavorableorientationsofimidazolecleavinggroupsin
terms of hydrolytic activity (see Figure 6 showing F1-Im(4/
2a) ﬁnal structure as an example). The possible reason of
this could be the presence of a deoxyribothymidine fragment
linking the oligonucleotide and the cleaving construct.
According to our data, the thymidine base is involved in
the DNA:RNA helix structure in a semistacking interaction
with the neighboring nucleotide residue dG1. The thymidine
base matches comfortably the duplex structure, although no
additional hydrogen bonding with the opposite strand was
detected (for instance, with the A62). This interaction could
control the overall conformation of the rest of the cleaving
construct and possibly restrict the conformational freedom
of this group, resulting in a decreased probability to render
an “active” conformation. This could explain the relativelyJournal of Nucleic Acids 13
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Figure 5: A fragment of the most favourable conformation, F4-
Im(4/1), found for hybrid complex H- Im(4/1) between artiﬁcial
ribonuclease B-Im(4/1) and tRNAPhe where the close proximity of
imidazole cleaving groups to the target sequence C63-A64 (green) is
evident. Hydrogen bonds are shown in yellow.
low hydrolytic activity of B-Im(4/2a) (16.6%) compared to
B-Im(4/1).
Even more pronounced decrease in hydrolytic activity
(down to 5–7%) was observed for conjugate B-Im(4/2b),
a structural analogue of B-Im(4/2a) with a shortened
linker group. Data obtained in biochemical assays are
consistent with results from molecular modeling for M-
Im(4/2b) (Table 2), showing that the most energetically
favorable conformations (for instance, F2-Im(4/2b), F3-
Im(4/2b), and F5-Im(4/2b)) have a distant location of the
cleaving groups relative to the target site (Figure 7 shows F5-
Im(4/2b)). Moreover, only one of two bis-imidazole groups
can occupy a position, favorable for cleaving activity. This
decreases the statistical probability of reaching an “active”
conformation for M-Im(4/2b). Generally, most of the ﬁnal
structures of M-Im(4/2b) are characterized by long distances
between imidazole rings and target atoms. Analysis of the
structural parameters showed that the length of the linker
group is not enough to provide a good chance to reach
the target site. This possibly contributes to the restricted
conformational freedom caused by thymidine interactions
with the RNA:DNA duplex structure (see above for M-
Im(4/2a)).Takentogether,theseexplainthelowesthydrolytic
activity for B-Im(4/2b) between the artiﬁcial ribonucleases.
Analysis of ﬁnal structures resulting from the simulating
annealing experiments shows a remarkable ability of all
cleaving constructs to form multiple hydrogen bonds that
generally can be represented by two types (Scheme 1). The
ﬁrst type is the intermolecular interactions between cleaving
constructs and the RNA target, which are formed by oxygen
atoms of the RNA phosphate backbone and either (i) by
imidazole rings of the cleaving groups or (ii) by protons of
the linker amido groups (see Scheme 1). These types of
hydrogen bonding seem to be in favor of the hydrolytic
activity of compounds due to their ability to stabilize the
location of cleaving groups, close to the RNA target. The sec-
ond type of possible hydrogen bonding (Scheme 1)r e f e r st o
intramolecularinteractionswithincleavingconstructsthem-
selves and involves interactions between imidazole rings and
amido groups, carbonyl groups and phosphate groups of
the linker. This type of hydrogen bond interaction also
includes intralinker bridges formed by amido and carbonyl/
phosphate groups. Intramolecular hydrogen bonds seem to
competewithfavorableintermolecularinteractions,prevent-
ing the imidazole groups from appropriate contacts with14 Journal of Nucleic Acids
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Figure 6: A fragment showing one possible conformation (namely,
ﬁnal structure F9-Im(4/2a)) of B-Im(4/2a) (4a) found for the
hybridcomplexH-Im(4/2a).Distancesbetweenthecleavinggroups
and the sequence C63-A64 (green) are indicated. The dT (magenta)
semistacking interaction with the dG1fragment is also shown.
Hydrogen atoms have been removed for easier visualization.
the RNA backbone, which may result in a decrease of their
hydrolytic activity.
Based on these results, we propose several suggestions on
how to improve further the cleaving potential of artiﬁcial
ribonucleases. First, it is important to avoid the use of any
carbonyl/phosphate groups within the linker in order to
decrease the possibility of intramolecular hydrogen bonding.
Secondly, it could be advantageous to introduce polycationic
groups within the linker, which might increase possible con-
tacts of cleaving groups with negatively charged phosphate
backbones of target RNA. Finally, the insertion of a suitable
hydrophobic/intercalating groups within the linker might
also increase chances for these groups to be located in
the vicinity of the RNA target due to additional stacking/
hydrophobic interactions with diﬀerent ribonucleotide envi-
ronments.
4. Conclusions
In the current research, we studied oligonucleotide-based
artiﬁcial ribonucleases containing multiple imidazole resi-
dues in the catalytic part of the aRNases with systematically
varied structure of cleaving constructs. All the conjugates
contain the same addressing oligonucleotide which provides
eﬃcient and almost quantitative binding of the conjugates to
the target sequence within the tRNA. This allows comparing
diﬀerent cleaving constructs in terms of site speciﬁcity and
eﬃciency of RNA cleavage. Obtained results let us conclude
that the eﬃciency of site-selective RNA cleavage is governed
by a number of dynamic parameters among which the most
important is the ﬂexibility of a linker between the catalytic
imidazole residues and the addressing oligonucleotide. The
other factors aﬀecting the eﬃciency of site-selective RNA
cleavage are the number of imidazole residues in the catalytic
A64
C63
Im
Im
dT
P-O5

2
OH
Figure 7: A fragment showing one possible conformation for the
hybrid complex between artiﬁcial ribonuclease B-Im(4/2b) and
tRNA.Inthisﬁnalconformation,F5-Im(4/2b),theimidazolecleav-
ing groups are located distant from the target sequence. The dT
linker fragment (magenta) shows interaction with the dG1 residue
in a semi-stacking interaction, possibly restricting the conforma-
tional freedom of this molecule. Hydrogen bonds are shown in
yellow.
part, the type of anchor group, connecting linker structure
and the oligonucleotide, and the length of a linker between
the catalytic imidazole groups of the construct and the oligo-
nucleotide. We found that four imidazole residues located in
the catalytic part of the conjugate can eﬃciently catalysed
cleavage of phosphodiester bond in the case when they are
locatedinthecloseproximity ofRNAsugar-phosphateback-
bone, while increasing of the number of imidazole groups
inhibits cleavage, possibly due to steric interference between
the imidazole residues.
Molecular modeling carried out to explain diﬀerences in
ribonucleaseactivityoftheconjugatesshowedthatpreferable
orientation(s) of cleaving constructs strongly depend on the
structure of the anchor group and length of the linker. The
inclusion of deoxyribothymidine as an anchor group signif-
icantly reduced the probability of cleaving groups to locate
near the cleavage site due to a stacking interaction with the
neighbouring nucleotide residue. Remarkably high cleavage
activitywasdisplayedbytheconjugateswiththemostﬂexible
and extended cleaving construct, which presumably provides
a better opportunity for imidazole residues to be correctly
positioned in the vicinity of scissile phosphodiester bond.
The other very important factor aﬀecting the eﬃciency
of site-selective RNA cleavage is sensitivity of phosphodiester
bonds of RNA toward cleavage. Diﬀerent catalytic structures
display some sequence preference [1]. On the other hand,
phosphodiester bonds in diﬀerent RNA sequence display
diﬀerent sensitivities to cleaving agents [3, 44–48]. These
factors should be taken into account when selecting targetJournal of Nucleic Acids 15
sites within speciﬁc RNAs. In our experiments, the cleaving
groups were targeted to CACA sequence of tRNAPhe, known
to be of particular sensitivity to cleavage by diﬀerent agents.
So, the ribonuclease activity of the conjugates was compared
under favourable conditions. On the other hand, binding
of oligonucleotide conjugates to target RNA is followed by
RNA structure rearrangements that can bring the target site
in favorable or unfavorable positions toward the catalytic
groups [32, 49, 50]. Thus, optimisation of the structure of
catalyticgroupsofoligonucleotide conjugatesandidentiﬁca-
tion of optimal structures of RNA for targeting with artiﬁcial
ribonucleases may facilitate the creation of highly speciﬁc
artiﬁcial ribonucleases of a new generation.
Results of the studies performed by the authors revealed
the problems to be solved in order to develop the highly eﬃ-
cientRNAcleavingoligonucleotideconjugates.Afewimpor-
tant factors determining eﬃcacy of RNA cleavage remain to
be investigated so that the oligonucleotide conjugates take
advantage of the known mechanisms used by natural en-
zymes for achieving high reaction rate.
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